Difference between revisions of "Caspofungin (Cancidas)"
Jump to navigation
Jump to search
| Line 2: | Line 2: | ||
== Patient Drug Information== | == Patient Drug Information== | ||
| − | *[https://www. | + | *[https://www.sanofi.in/-/media/Project/One-Sanofi-Web/Websites/Asia-Pacific/Sanofi-IN/Home/science-and-innovation/for-healthcare-professionals/product-information/CASPERCID-June-2018-final.pdf?la=en Caspofungin (Cancidas) Package Insert]<ref>[https://www.sanofi.in/-/media/Project/One-Sanofi-Web/Websites/Asia-Pacific/Sanofi-IN/Home/science-and-innovation/for-healthcare-professionals/product-information/CASPERCID-June-2018-final.pdf?la=en Caspofungin (Cancidas) Package Insert]</ref><ref>[[Media:Caspofungin.pdf | Caspofungin (Cancidas) package insert (locally hosted backup)]]</ref> |
==Also known as== | ==Also known as== | ||
Revision as of 17:06, 27 May 2021
Lipopeptide antifungal, no known antineoplastic properties.
Patient Drug Information
Also known as
- Brand names: Cagin, Cancidas, Capsain, Caspogin, Caspoliv, Casponova, Guficap, Kabifungin, Letocan, Profung, Wofungin